Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986986 · ClinicalTrials.gov registry record · NA
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
A NA study, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00986986 is a NA study that has completed, run by University of Hawaii. The registered enrollment target is 20 participants.
The verdict
NCT00986986, a NA study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is a pilot study examining the effect of extended-release niacin (Niaspan ®) on flow-mediated vasodilation (FMD) of the brachial artery, among human immunodeficiency virus (HIV)-1 infected individuals with low high density lipoprotein (HDL). Brachial artery diameter will be measured by high-resolution ultrasound at entry and week 12 of study. The primary comparisons will be change in FMD from baseline to 12 weeks within each of the two arms. The second specific aim will be to investigate the proportion of the effect of extended-release niacin on other known cardiovascular markers.
Interventions
- DRUG extended release niacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00986986
The ClinicalTrials.gov registry entry for NCT00986986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which extended release niacin is the first listed.
NCT00986986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00986986 about?
NCT00986986 is a clinical study titled "Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels". This study is a pilot study examining the effect of extended-release niacin (Niaspan ®) on flow-mediated vasodilation (FMD) of the brachial artery, among human immunodeficiency virus (HIV)-1 infected individuals with low high density lipoprotein (HDL). Brachial artery diameter will be measured by hi...
What is the current status of trial NCT00986986?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-11. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00986986?
The interventions under investigation include: extended release niacin (DRUG).
Who is sponsoring clinical trial NCT00986986?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.